Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices

Osteoporotic fractures, also known as fragility fractures, are reflective of compromised bone strength and are associated with significant morbidity and mortality. Such fractures may be clinically silent, and others may present clinically with pain and deformity at the time of the injury. Unfortunat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Mayo Clinic proceedings 2024-07, Vol.99 (7), p.1127-1141
Hauptverfasser: Khan, Aliya A., Slart, Riemer H.J.A., Ali, Dalal S., Bock, Oliver, Carey, John J., Camacho, Pauline, Engelke, Klaus, Erba, Paola A., Harvey, Nicholas C., Lems, Willem F., Morgan, Sarah, Moseley, Kendall F., O’Brien, Christopher, Probyn, Linda, Punda, Marija, Richmond, Bradford, Schousboe, John T., Shuhart, Christopher, Ward, Kate A., Lewiecki, E. Michael
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1141
container_issue 7
container_start_page 1127
container_title Mayo Clinic proceedings
container_volume 99
creator Khan, Aliya A.
Slart, Riemer H.J.A.
Ali, Dalal S.
Bock, Oliver
Carey, John J.
Camacho, Pauline
Engelke, Klaus
Erba, Paola A.
Harvey, Nicholas C.
Lems, Willem F.
Morgan, Sarah
Moseley, Kendall F.
O’Brien, Christopher
Probyn, Linda
Punda, Marija
Richmond, Bradford
Schousboe, John T.
Shuhart, Christopher
Ward, Kate A.
Lewiecki, E. Michael
description Osteoporotic fractures, also known as fragility fractures, are reflective of compromised bone strength and are associated with significant morbidity and mortality. Such fractures may be clinically silent, and others may present clinically with pain and deformity at the time of the injury. Unfortunately, and even at the time of detection, most individuals sustaining fragility fractures are not identified as having underlying metabolic bone disease and are not evaluated or treated to reduce the incidence of future fractures. A multidisciplinary international working group with representation from international societies dedicated to advancing the care of patients with metabolic bone disease has developed best practice recommendations for the diagnosis and evaluation of individuals with fragility fractures. A comprehensive narrative review was conducted to identify key articles on fragility fractures and their impact on the incidence of further fractures, morbidity, and mortality. This document represents consensus among the supporting societies and harmonizes best practice recommendations consistent with advances in research. A fragility fracture in an adult is an important predictor of future fractures and requires further evaluation and treatment of the underlying osteoporosis. It is important to recognize that most fragility fractures occur in patients with bone mineral density T scores higher than −2.5, and these fractures confirm the presence of skeletal fragility even in the presence of a well-maintained bone mineral density. Fragility fractures require further evaluation with exclusion of contributing factors for osteoporosis and assessment of clinical risk factors for fracture followed by appropriate pharmacological intervention designed to reduce the risk of future fracture. Because most low-trauma vertebral fractures do not present with pain, dedicated vertebral imaging and review of past imaging is useful in identifying fractures in patients at high risk for vertebral fractures. Given the importance of fractures in confirming skeletal fragility and predicting future events, it is recommended that an established classification system be used for fracture identification and reporting.
doi_str_mv 10.1016/j.mayocp.2024.01.011
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_3075701832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A804160634</galeid><els_id>S0025619624000478</els_id><sourcerecordid>A804160634</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-e2b607f533ca3f4df4b72f00a9c2ed2204aad7afc233f3397426aabca0bdf78c3</originalsourceid><addsrcrecordid>eNp9kVuLFDEQhRtR3HH1H4jkSXzYGSuX6Z72QRj35sLCCir6FmrSlZmM3cmYpBfWX2_GWUVfJAWB4jtVhzpV9ZzDjAOvX29nA94Fs5sJEGoGvBR_UE14q8R0Plf1w2oCIObTmrf1UfUkpS0ANG2rHldHctHWoNpmUv24SZnCLsSQnWEXEU0eI6U37Mzh2ofk0gk7v8V-xOyCP2HoO_bRrb2zzqA3VCRhYHlD7Mpniv4Xhj37EuI359fsMoZxx4JnZ1-X7B2lzD7sdzhD6Wn1yGKf6Nn9f1x9vjj_dPp-en1zeXW6vJ4aWYs8JbGqobFzKQ1KqzqrVo2wANgaQZ0QoBC7Bq0RUlop20aJGnFlEFadbRZGHlevDnN3MXwfiwU9uGSo79FTGJOW0Mwb4AspCjo7oGvsSTtvQy5uy-tocCZ4sq70lwtQvIZaqiJ4-ZdgQ9jnTQr9uL9C-hdUB9DEkFIkq3fRDRjvNAe9z1Nv9SFPvc9TAy_Fi-zFvfdxNVD3R_Q7wAK8PQBULnjrKOpkHJVgOhfJZN0F9_8NPwHvebPR</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3075701832</pqid></control><display><type>article</type><title>Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>Khan, Aliya A. ; Slart, Riemer H.J.A. ; Ali, Dalal S. ; Bock, Oliver ; Carey, John J. ; Camacho, Pauline ; Engelke, Klaus ; Erba, Paola A. ; Harvey, Nicholas C. ; Lems, Willem F. ; Morgan, Sarah ; Moseley, Kendall F. ; O’Brien, Christopher ; Probyn, Linda ; Punda, Marija ; Richmond, Bradford ; Schousboe, John T. ; Shuhart, Christopher ; Ward, Kate A. ; Lewiecki, E. Michael</creator><creatorcontrib>Khan, Aliya A. ; Slart, Riemer H.J.A. ; Ali, Dalal S. ; Bock, Oliver ; Carey, John J. ; Camacho, Pauline ; Engelke, Klaus ; Erba, Paola A. ; Harvey, Nicholas C. ; Lems, Willem F. ; Morgan, Sarah ; Moseley, Kendall F. ; O’Brien, Christopher ; Probyn, Linda ; Punda, Marija ; Richmond, Bradford ; Schousboe, John T. ; Shuhart, Christopher ; Ward, Kate A. ; Lewiecki, E. Michael ; International Working Group on DXA Best Practices</creatorcontrib><description>Osteoporotic fractures, also known as fragility fractures, are reflective of compromised bone strength and are associated with significant morbidity and mortality. Such fractures may be clinically silent, and others may present clinically with pain and deformity at the time of the injury. Unfortunately, and even at the time of detection, most individuals sustaining fragility fractures are not identified as having underlying metabolic bone disease and are not evaluated or treated to reduce the incidence of future fractures. A multidisciplinary international working group with representation from international societies dedicated to advancing the care of patients with metabolic bone disease has developed best practice recommendations for the diagnosis and evaluation of individuals with fragility fractures. A comprehensive narrative review was conducted to identify key articles on fragility fractures and their impact on the incidence of further fractures, morbidity, and mortality. This document represents consensus among the supporting societies and harmonizes best practice recommendations consistent with advances in research. A fragility fracture in an adult is an important predictor of future fractures and requires further evaluation and treatment of the underlying osteoporosis. It is important to recognize that most fragility fractures occur in patients with bone mineral density T scores higher than −2.5, and these fractures confirm the presence of skeletal fragility even in the presence of a well-maintained bone mineral density. Fragility fractures require further evaluation with exclusion of contributing factors for osteoporosis and assessment of clinical risk factors for fracture followed by appropriate pharmacological intervention designed to reduce the risk of future fracture. Because most low-trauma vertebral fractures do not present with pain, dedicated vertebral imaging and review of past imaging is useful in identifying fractures in patients at high risk for vertebral fractures. Given the importance of fractures in confirming skeletal fragility and predicting future events, it is recommended that an established classification system be used for fracture identification and reporting.</description><identifier>ISSN: 0025-6196</identifier><identifier>ISSN: 1942-5546</identifier><identifier>EISSN: 1942-5546</identifier><identifier>DOI: 10.1016/j.mayocp.2024.01.011</identifier><identifier>PMID: 38960497</identifier><language>eng</language><publisher>England: Elsevier Inc</publisher><subject>Absorptiometry, Photon - methods ; Biotechnology industry ; Bone Density ; Canada ; Care and treatment ; Denosumab ; Diagnosis ; Female ; Health aspects ; Humans ; Mortality ; Osteoporosis ; Osteoporosis - diagnosis ; Osteoporosis - diagnostic imaging ; Osteoporotic Fractures - diagnosis ; Osteoporotic Fractures - diagnostic imaging ; Osteoporotic Fractures - prevention &amp; control ; Practice Guidelines as Topic ; Risk Factors ; United States</subject><ispartof>Mayo Clinic proceedings, 2024-07, Vol.99 (7), p.1127-1141</ispartof><rights>2024 The Authors</rights><rights>Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.</rights><rights>COPYRIGHT 2024 Elsevier, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-e2b607f533ca3f4df4b72f00a9c2ed2204aad7afc233f3397426aabca0bdf78c3</citedby><cites>FETCH-LOGICAL-c362t-e2b607f533ca3f4df4b72f00a9c2ed2204aad7afc233f3397426aabca0bdf78c3</cites><orcidid>0000-0002-2669-4173 ; 0000-0002-8194-2512 ; 0000-0002-6885-3953 ; 0000-0001-9875-4123 ; 0000-0001-7034-6750 ; 0000-0003-3733-8956 ; 0000-0002-9329-0750 ; 0000-0003-2026-9587 ; 0000-0002-4645-9170 ; 0000-0002-5565-1164 ; 0000-0003-2500-2312 ; 0000-0002-5378-5548 ; 0000-0001-7292-2328</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38960497$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Khan, Aliya A.</creatorcontrib><creatorcontrib>Slart, Riemer H.J.A.</creatorcontrib><creatorcontrib>Ali, Dalal S.</creatorcontrib><creatorcontrib>Bock, Oliver</creatorcontrib><creatorcontrib>Carey, John J.</creatorcontrib><creatorcontrib>Camacho, Pauline</creatorcontrib><creatorcontrib>Engelke, Klaus</creatorcontrib><creatorcontrib>Erba, Paola A.</creatorcontrib><creatorcontrib>Harvey, Nicholas C.</creatorcontrib><creatorcontrib>Lems, Willem F.</creatorcontrib><creatorcontrib>Morgan, Sarah</creatorcontrib><creatorcontrib>Moseley, Kendall F.</creatorcontrib><creatorcontrib>O’Brien, Christopher</creatorcontrib><creatorcontrib>Probyn, Linda</creatorcontrib><creatorcontrib>Punda, Marija</creatorcontrib><creatorcontrib>Richmond, Bradford</creatorcontrib><creatorcontrib>Schousboe, John T.</creatorcontrib><creatorcontrib>Shuhart, Christopher</creatorcontrib><creatorcontrib>Ward, Kate A.</creatorcontrib><creatorcontrib>Lewiecki, E. Michael</creatorcontrib><creatorcontrib>International Working Group on DXA Best Practices</creatorcontrib><title>Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices</title><title>Mayo Clinic proceedings</title><addtitle>Mayo Clin Proc</addtitle><description>Osteoporotic fractures, also known as fragility fractures, are reflective of compromised bone strength and are associated with significant morbidity and mortality. Such fractures may be clinically silent, and others may present clinically with pain and deformity at the time of the injury. Unfortunately, and even at the time of detection, most individuals sustaining fragility fractures are not identified as having underlying metabolic bone disease and are not evaluated or treated to reduce the incidence of future fractures. A multidisciplinary international working group with representation from international societies dedicated to advancing the care of patients with metabolic bone disease has developed best practice recommendations for the diagnosis and evaluation of individuals with fragility fractures. A comprehensive narrative review was conducted to identify key articles on fragility fractures and their impact on the incidence of further fractures, morbidity, and mortality. This document represents consensus among the supporting societies and harmonizes best practice recommendations consistent with advances in research. A fragility fracture in an adult is an important predictor of future fractures and requires further evaluation and treatment of the underlying osteoporosis. It is important to recognize that most fragility fractures occur in patients with bone mineral density T scores higher than −2.5, and these fractures confirm the presence of skeletal fragility even in the presence of a well-maintained bone mineral density. Fragility fractures require further evaluation with exclusion of contributing factors for osteoporosis and assessment of clinical risk factors for fracture followed by appropriate pharmacological intervention designed to reduce the risk of future fracture. Because most low-trauma vertebral fractures do not present with pain, dedicated vertebral imaging and review of past imaging is useful in identifying fractures in patients at high risk for vertebral fractures. Given the importance of fractures in confirming skeletal fragility and predicting future events, it is recommended that an established classification system be used for fracture identification and reporting.</description><subject>Absorptiometry, Photon - methods</subject><subject>Biotechnology industry</subject><subject>Bone Density</subject><subject>Canada</subject><subject>Care and treatment</subject><subject>Denosumab</subject><subject>Diagnosis</subject><subject>Female</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Mortality</subject><subject>Osteoporosis</subject><subject>Osteoporosis - diagnosis</subject><subject>Osteoporosis - diagnostic imaging</subject><subject>Osteoporotic Fractures - diagnosis</subject><subject>Osteoporotic Fractures - diagnostic imaging</subject><subject>Osteoporotic Fractures - prevention &amp; control</subject><subject>Practice Guidelines as Topic</subject><subject>Risk Factors</subject><subject>United States</subject><issn>0025-6196</issn><issn>1942-5546</issn><issn>1942-5546</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kVuLFDEQhRtR3HH1H4jkSXzYGSuX6Z72QRj35sLCCir6FmrSlZmM3cmYpBfWX2_GWUVfJAWB4jtVhzpV9ZzDjAOvX29nA94Fs5sJEGoGvBR_UE14q8R0Plf1w2oCIObTmrf1UfUkpS0ANG2rHldHctHWoNpmUv24SZnCLsSQnWEXEU0eI6U37Mzh2ofk0gk7v8V-xOyCP2HoO_bRrb2zzqA3VCRhYHlD7Mpniv4Xhj37EuI359fsMoZxx4JnZ1-X7B2lzD7sdzhD6Wn1yGKf6Nn9f1x9vjj_dPp-en1zeXW6vJ4aWYs8JbGqobFzKQ1KqzqrVo2wANgaQZ0QoBC7Bq0RUlop20aJGnFlEFadbRZGHlevDnN3MXwfiwU9uGSo79FTGJOW0Mwb4AspCjo7oGvsSTtvQy5uy-tocCZ4sq70lwtQvIZaqiJ4-ZdgQ9jnTQr9uL9C-hdUB9DEkFIkq3fRDRjvNAe9z1Nv9SFPvc9TAy_Fi-zFvfdxNVD3R_Q7wAK8PQBULnjrKOpkHJVgOhfJZN0F9_8NPwHvebPR</recordid><startdate>202407</startdate><enddate>202407</enddate><creator>Khan, Aliya A.</creator><creator>Slart, Riemer H.J.A.</creator><creator>Ali, Dalal S.</creator><creator>Bock, Oliver</creator><creator>Carey, John J.</creator><creator>Camacho, Pauline</creator><creator>Engelke, Klaus</creator><creator>Erba, Paola A.</creator><creator>Harvey, Nicholas C.</creator><creator>Lems, Willem F.</creator><creator>Morgan, Sarah</creator><creator>Moseley, Kendall F.</creator><creator>O’Brien, Christopher</creator><creator>Probyn, Linda</creator><creator>Punda, Marija</creator><creator>Richmond, Bradford</creator><creator>Schousboe, John T.</creator><creator>Shuhart, Christopher</creator><creator>Ward, Kate A.</creator><creator>Lewiecki, E. Michael</creator><general>Elsevier Inc</general><general>Elsevier, Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2669-4173</orcidid><orcidid>https://orcid.org/0000-0002-8194-2512</orcidid><orcidid>https://orcid.org/0000-0002-6885-3953</orcidid><orcidid>https://orcid.org/0000-0001-9875-4123</orcidid><orcidid>https://orcid.org/0000-0001-7034-6750</orcidid><orcidid>https://orcid.org/0000-0003-3733-8956</orcidid><orcidid>https://orcid.org/0000-0002-9329-0750</orcidid><orcidid>https://orcid.org/0000-0003-2026-9587</orcidid><orcidid>https://orcid.org/0000-0002-4645-9170</orcidid><orcidid>https://orcid.org/0000-0002-5565-1164</orcidid><orcidid>https://orcid.org/0000-0003-2500-2312</orcidid><orcidid>https://orcid.org/0000-0002-5378-5548</orcidid><orcidid>https://orcid.org/0000-0001-7292-2328</orcidid></search><sort><creationdate>202407</creationdate><title>Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices</title><author>Khan, Aliya A. ; Slart, Riemer H.J.A. ; Ali, Dalal S. ; Bock, Oliver ; Carey, John J. ; Camacho, Pauline ; Engelke, Klaus ; Erba, Paola A. ; Harvey, Nicholas C. ; Lems, Willem F. ; Morgan, Sarah ; Moseley, Kendall F. ; O’Brien, Christopher ; Probyn, Linda ; Punda, Marija ; Richmond, Bradford ; Schousboe, John T. ; Shuhart, Christopher ; Ward, Kate A. ; Lewiecki, E. Michael</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-e2b607f533ca3f4df4b72f00a9c2ed2204aad7afc233f3397426aabca0bdf78c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Absorptiometry, Photon - methods</topic><topic>Biotechnology industry</topic><topic>Bone Density</topic><topic>Canada</topic><topic>Care and treatment</topic><topic>Denosumab</topic><topic>Diagnosis</topic><topic>Female</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Mortality</topic><topic>Osteoporosis</topic><topic>Osteoporosis - diagnosis</topic><topic>Osteoporosis - diagnostic imaging</topic><topic>Osteoporotic Fractures - diagnosis</topic><topic>Osteoporotic Fractures - diagnostic imaging</topic><topic>Osteoporotic Fractures - prevention &amp; control</topic><topic>Practice Guidelines as Topic</topic><topic>Risk Factors</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Khan, Aliya A.</creatorcontrib><creatorcontrib>Slart, Riemer H.J.A.</creatorcontrib><creatorcontrib>Ali, Dalal S.</creatorcontrib><creatorcontrib>Bock, Oliver</creatorcontrib><creatorcontrib>Carey, John J.</creatorcontrib><creatorcontrib>Camacho, Pauline</creatorcontrib><creatorcontrib>Engelke, Klaus</creatorcontrib><creatorcontrib>Erba, Paola A.</creatorcontrib><creatorcontrib>Harvey, Nicholas C.</creatorcontrib><creatorcontrib>Lems, Willem F.</creatorcontrib><creatorcontrib>Morgan, Sarah</creatorcontrib><creatorcontrib>Moseley, Kendall F.</creatorcontrib><creatorcontrib>O’Brien, Christopher</creatorcontrib><creatorcontrib>Probyn, Linda</creatorcontrib><creatorcontrib>Punda, Marija</creatorcontrib><creatorcontrib>Richmond, Bradford</creatorcontrib><creatorcontrib>Schousboe, John T.</creatorcontrib><creatorcontrib>Shuhart, Christopher</creatorcontrib><creatorcontrib>Ward, Kate A.</creatorcontrib><creatorcontrib>Lewiecki, E. Michael</creatorcontrib><creatorcontrib>International Working Group on DXA Best Practices</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Mayo Clinic proceedings</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Khan, Aliya A.</au><au>Slart, Riemer H.J.A.</au><au>Ali, Dalal S.</au><au>Bock, Oliver</au><au>Carey, John J.</au><au>Camacho, Pauline</au><au>Engelke, Klaus</au><au>Erba, Paola A.</au><au>Harvey, Nicholas C.</au><au>Lems, Willem F.</au><au>Morgan, Sarah</au><au>Moseley, Kendall F.</au><au>O’Brien, Christopher</au><au>Probyn, Linda</au><au>Punda, Marija</au><au>Richmond, Bradford</au><au>Schousboe, John T.</au><au>Shuhart, Christopher</au><au>Ward, Kate A.</au><au>Lewiecki, E. Michael</au><aucorp>International Working Group on DXA Best Practices</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices</atitle><jtitle>Mayo Clinic proceedings</jtitle><addtitle>Mayo Clin Proc</addtitle><date>2024-07</date><risdate>2024</risdate><volume>99</volume><issue>7</issue><spage>1127</spage><epage>1141</epage><pages>1127-1141</pages><issn>0025-6196</issn><issn>1942-5546</issn><eissn>1942-5546</eissn><abstract>Osteoporotic fractures, also known as fragility fractures, are reflective of compromised bone strength and are associated with significant morbidity and mortality. Such fractures may be clinically silent, and others may present clinically with pain and deformity at the time of the injury. Unfortunately, and even at the time of detection, most individuals sustaining fragility fractures are not identified as having underlying metabolic bone disease and are not evaluated or treated to reduce the incidence of future fractures. A multidisciplinary international working group with representation from international societies dedicated to advancing the care of patients with metabolic bone disease has developed best practice recommendations for the diagnosis and evaluation of individuals with fragility fractures. A comprehensive narrative review was conducted to identify key articles on fragility fractures and their impact on the incidence of further fractures, morbidity, and mortality. This document represents consensus among the supporting societies and harmonizes best practice recommendations consistent with advances in research. A fragility fracture in an adult is an important predictor of future fractures and requires further evaluation and treatment of the underlying osteoporosis. It is important to recognize that most fragility fractures occur in patients with bone mineral density T scores higher than −2.5, and these fractures confirm the presence of skeletal fragility even in the presence of a well-maintained bone mineral density. Fragility fractures require further evaluation with exclusion of contributing factors for osteoporosis and assessment of clinical risk factors for fracture followed by appropriate pharmacological intervention designed to reduce the risk of future fracture. Because most low-trauma vertebral fractures do not present with pain, dedicated vertebral imaging and review of past imaging is useful in identifying fractures in patients at high risk for vertebral fractures. Given the importance of fractures in confirming skeletal fragility and predicting future events, it is recommended that an established classification system be used for fracture identification and reporting.</abstract><cop>England</cop><pub>Elsevier Inc</pub><pmid>38960497</pmid><doi>10.1016/j.mayocp.2024.01.011</doi><tpages>15</tpages><orcidid>https://orcid.org/0000-0002-2669-4173</orcidid><orcidid>https://orcid.org/0000-0002-8194-2512</orcidid><orcidid>https://orcid.org/0000-0002-6885-3953</orcidid><orcidid>https://orcid.org/0000-0001-9875-4123</orcidid><orcidid>https://orcid.org/0000-0001-7034-6750</orcidid><orcidid>https://orcid.org/0000-0003-3733-8956</orcidid><orcidid>https://orcid.org/0000-0002-9329-0750</orcidid><orcidid>https://orcid.org/0000-0003-2026-9587</orcidid><orcidid>https://orcid.org/0000-0002-4645-9170</orcidid><orcidid>https://orcid.org/0000-0002-5565-1164</orcidid><orcidid>https://orcid.org/0000-0003-2500-2312</orcidid><orcidid>https://orcid.org/0000-0002-5378-5548</orcidid><orcidid>https://orcid.org/0000-0001-7292-2328</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0025-6196
ispartof Mayo Clinic proceedings, 2024-07, Vol.99 (7), p.1127-1141
issn 0025-6196
1942-5546
1942-5546
language eng
recordid cdi_proquest_miscellaneous_3075701832
source MEDLINE; Alma/SFX Local Collection
subjects Absorptiometry, Photon - methods
Biotechnology industry
Bone Density
Canada
Care and treatment
Denosumab
Diagnosis
Female
Health aspects
Humans
Mortality
Osteoporosis
Osteoporosis - diagnosis
Osteoporosis - diagnostic imaging
Osteoporotic Fractures - diagnosis
Osteoporotic Fractures - diagnostic imaging
Osteoporotic Fractures - prevention & control
Practice Guidelines as Topic
Risk Factors
United States
title Osteoporotic Fractures: Diagnosis, Evaluation, and Significance From the International Working Group on DXA Best Practices
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-01T21%3A42%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Osteoporotic%20Fractures:%20Diagnosis,%20Evaluation,%20and%20Significance%20From%20the%20International%20Working%20Group%20on%20DXA%20Best%20Practices&rft.jtitle=Mayo%20Clinic%20proceedings&rft.au=Khan,%20Aliya%20A.&rft.aucorp=International%20Working%20Group%20on%20DXA%20Best%20Practices&rft.date=2024-07&rft.volume=99&rft.issue=7&rft.spage=1127&rft.epage=1141&rft.pages=1127-1141&rft.issn=0025-6196&rft.eissn=1942-5546&rft_id=info:doi/10.1016/j.mayocp.2024.01.011&rft_dat=%3Cgale_proqu%3EA804160634%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3075701832&rft_id=info:pmid/38960497&rft_galeid=A804160634&rft_els_id=S0025619624000478&rfr_iscdi=true